Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: ANKE BIO(300009) the Revenue is 556.18 M (-16.17%);the EBIT is 192.95 M (+6.62%);the EPS is 0.1 (+0.96%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.56B16.17%
----
----
EBIT
0.19B6.62%
----
----
EPS
0.10.96%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf